Measuring tumor sugar use with a new PET scan method
Tests a new PET scan method for tumor sugar use in adults with lung cancer.
Plain-language title generated from the registry record
Registry title: Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET
Key facts
- Where
- Maastricht, NetherlandsSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with lung cancer or lymphoma who are already having a standard 18F FDG PET/CT scan. An extra dynamic scan and blood tests are added.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Earlier treatment
- People who had earlier radiotherapy or chemotherapy for carcinoma cannot join.
Main reasons for not taking part
- Diabetes (fasted blood glucose above 7 mmol/L (126 mg/dL))
- Not fasted for more than 4 hours
- Physical exercise within 24 hours
- Active inflammation (fever above 38 degrees, CRP above 5)
- Pregnant or breast feeding
Read by machine on 12 November 2026.
Where in Netherlands
- Academisch Ziekenhuis MaastrichtMaastricht, NetherlandsContact: Sam Springer, MScTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Academisch Ziekenhuis Maastricht
- Trial code
- NCT05654675
- Record updated
- 29 January 2025
- Original description
The goal of this study is to evaluate the use of new method to quantify the amount of sugar a tumor consumes using PET/CT. The main questions it aims to answer are:Read full original descriptionShow less
Evaluation of the Fractional Uptake Rate (FUR) in 18F-FDG PET/CT to Assess Tumour Metabolic Activity
The goal of this study is to evaluate the use of new method to quantify the amount of sugar a tumor consumes using PET/CT. The main questions it aims to answer are:
* Is the new quantification method superior with respect to the method currently used in the clinic? * Does the new quantification method provide accurate assessment of the sugar consumption of tumours?
Participants who will undergo a standard care FDG PET/CT scan will in additional receive a dynamic PET/CT scan prior to the standard care scan. In addition blood samples will be drawn at three time points during the examination.
Inclusion: Patients who receive an 18F FDG PET/CT scan as part of standard care; Be competent and be 18 years of age or older.
Exclusion: Earlier treatment for carcinoma with radio/chemo-therapy; Any condition or medical indication (such as claustrophobia) that indicates that the patient will not be able to lie still for the duration of the dynamic PET/CT examination; Diabetes (fasted blood glucose > 7 mmol/L); Not fasted > 4 hours; Physical exercise within 24 hours; Active inflammation (fever > 38 degrees, CRP > 5); Pregnant or breast feeding.